Mutual of America Capital Management LLC Trims Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Mutual of America Capital Management LLC decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,639 shares of the company’s stock after selling 546 shares during the period. Mutual of America Capital Management LLC’s holdings in Henry Schein were worth $1,140,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of HSIC. California State Teachers Retirement System lifted its holdings in shares of Henry Schein by 1.7% in the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock worth $16,018,000 after buying an additional 3,534 shares during the period. Tidal Investments LLC lifted its stake in Henry Schein by 21.4% in the first quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock worth $425,000 after acquiring an additional 994 shares during the period. Wahed Invest LLC grew its holdings in Henry Schein by 14.3% during the 1st quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock worth $192,000 after acquiring an additional 318 shares in the last quarter. Swedbank AB purchased a new position in Henry Schein during the 1st quarter valued at about $215,998,000. Finally, DNB Asset Management AS raised its holdings in shares of Henry Schein by 18.5% in the 2nd quarter. DNB Asset Management AS now owns 26,731 shares of the company’s stock valued at $1,713,000 after purchasing an additional 4,176 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $76.84 on Tuesday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a market cap of $9.58 billion, a PE ratio of 31.62, a P/E/G ratio of 2.15 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business has a 50-day simple moving average of $70.89 and a two-hundred day simple moving average of $69.73.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period last year, the business earned $1.32 EPS. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. As a group, equities analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analysts Set New Price Targets

HSIC has been the topic of several research reports. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. UBS Group reduced their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Evercore ISI raised their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Finally, Barrington Research reiterated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.